十二指腸內視鏡市場機會、成長要素、產業趨勢分析及2026-2035年預測

全球十二指腸內視鏡市場預計到 2025 年價值 1.91 億美元，預計到 2035 年將以 5.9% 的複合年成長率成長至 3.354 億美元。

十二指腸內視鏡產業的成長主要受以下因素驅動：對微創醫療程序的需求不斷成長、消化器官系統疾病盛行率上升以及內視鏡技術在治療領域的應用日益廣泛。十二指腸內視鏡是一種專門設計的柔軟性醫療器械，用於評估和治療影響小腸上段的疾病。醫生廣泛使用這些器械來診斷和治療與胃腸道及其相關器官有關的疾病。人們對胃腸道健康的日益重視以及早期篩檢工作的持續發展，促使患者接受診斷性檢查。此外，許多已開發地區醫療保險覆蓋範圍的擴大，也使得患者更容易獲得先進的診斷技術。同時，全球人口老化增加了消化器官系統和肝胰腺疾病的風險，這也持續推高了對專用診斷設備的需求。此外，十二指腸內視鏡在治療性介入的應用日益廣泛，也使其臨床意義更加深遠。成像能力、安全機制和儀器人體工學的持續技術進步也在改善檢查結果，並加速醫療機構的採用。

預計到2035年，可重複使用十二指腸鏡市場將以5.6%的複合年成長率成長，達到2.537億美元。由於初始投資可透過長期重複使用來抵消，可重複使用設備在醫療服務量大的機構中仍廣泛應用。預算有限的醫療機構也常因其成本效益而選擇可重複使用型號。現代可重複使用十二指腸鏡設計採用可拆卸組件，簡化了清潔流程，並有助於降低污染風險。此外，配備高清視覺化技術和先進影像處理功能的可重複使用設備在複雜的診斷和治療過程中繼續發揮至關重要的作用。

預計到2025年，視訊十二指腸鏡市場規模將達到1.651億美元。視訊十二指腸鏡能夠增強消化道的可視性，使臨床醫生能夠進行更精準的檢查和操作。先進的影像技術使醫護人員能夠即時評估解剖結構，從而提高手術過程中臨床決策的準確性。高品質的可視化功能也促進了微創內視鏡手術的廣泛應用。此外，影像技術和智慧診斷工具的創新正在不斷提高視訊十二指腸鏡系統的準確性和可靠性。同時，新型設備設計更加輕巧、符合人體工學，從而延長了手術時間，並提高了醫護人員的操作便利性。

預計2025年，美國十二指腸內視鏡市場規模將達7,450萬美元。美國市場強勁的需求主要源自於消化器官系統疾病的高發生率，這些疾病需要專業的診斷和治療。美國醫療機構正擴大採用先進的內視鏡技術來提高診斷準確性和治療效果。成像技術的持續創新以及先進可視化功能的整合，進一步推動了醫院和專科醫療中心對尖端十二指腸內視鏡系統的需求。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策和資料完整性計劃
    • 資訊來源一致性通訊協定
• 調查過程和可靠性評分
  • 調查過程的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 每種方法中基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 胃腸道疾病盛行率增加
    • 醫療設備的技術進步
    • 提高認知度和診斷率
  • 產業潛在風險與挑戰
    • 高成本和嚴格的監管要求
  • 市場機遇
    • 人工智慧和數據分析的融合激增
• 成長潛力分析
• 監理情勢
• 管道分析
• 2025年價格分析（基於初步調查）
• 救贖方案
• 消費者洞察（基於初步研究）
• 科技趨勢
  • 目前技術
  • 新興技術
• 差距分析
• 人工智慧和生成式人工智慧對市場的影響
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
  • LAMEA
• 競爭定位矩陣
• 主要市場公司的競爭分析
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品類型發布
  • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

• 可重複使用的十二指腸鏡
• 免洗十二指腸鏡

第6章 市場估計與預測：依類別分類，2022-2035年

• 影片十二指腸鏡
• 光纖十二指腸內視鏡

第7章 市場估價與預測：依銷售管道分類，2022-2035年

• 直銷
• 銷售代理

第8章 市場估算與預測：依最終用途分類，2022-2035年

• 醫院
• 門診手術中心
• 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Ambu
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Olympus Corporation
• Ottomed Endoscopy
• PENTAX MEDICAL
• SonoScape
• STORZ

The Global Duodenoscopes Market was valued at USD 191 million in 2025 and is estimated to grow at a CAGR of 5.9% to reach USD 335.4 million by 2035.

Growth across the duodenoscope industry is supported by the rising demand for minimally invasive medical procedures, the growing prevalence of digestive system disorders, and expanding therapeutic applications of endoscopic technologies. Duodenoscopes are specialized flexible medical instruments designed to evaluate and treat conditions affecting the upper section of the small intestine. These devices are widely used in procedures that allow physicians to diagnose and manage disorders related to the digestive tract and associated organs. Increasing awareness regarding digestive health and the expansion of early screening initiatives are encouraging patients to undergo diagnostic examinations. In addition, improved access to healthcare coverage in many developed regions allows patients to utilize advanced diagnostic technologies more easily. The global aging population is also more susceptible to digestive and hepatopancreatic conditions, which continues to increase the need for specialized diagnostic equipment. Furthermore, the growing use of duodenoscopes for therapeutic interventions has expanded their clinical significance. Continuous technological improvements in imaging capabilities, safety mechanisms, and device ergonomics are also enhancing procedure outcomes and increasing adoption across healthcare facilities.

The reusable duodenoscopes segment is expected to grow at a CAGR of 5.6% and is projected to reach USD 253.7 million by 2035. Reusable devices remain widely utilized in healthcare facilities with high procedural volumes because the initial investment can be offset through repeated usage over time. Medical institutions operating with constrained budgets often rely on reusable models due to their cost efficiency. Modern reusable duodenoscope designs incorporate detachable components that simplify cleaning processes and help reduce contamination risks. In addition, reusable devices equipped with high-definition visualization technologies and advanced imaging capabilities continue to play a crucial role in complex diagnostic and therapeutic procedures.

The video duodenoscopes segment generated USD 165.1 million in 2025. Video-based duodenoscopes provide enhanced visualization of the digestive tract, enabling clinicians to perform more accurate examinations and interventions. Advanced imaging technologies allow healthcare professionals to assess anatomical structures in real time, supporting improved clinical decision-making during procedures. High-quality visualization capabilities also contribute to the increased adoption of minimally invasive endoscopic procedures. Furthermore, innovations in imaging technologies and intelligent diagnostic tools are improving the precision and reliability of video duodenoscope systems. Newer device designs are also lighter and more ergonomic, which supports longer procedures and improves usability for medical professionals.

U.S. Duodenoscopes Market generated USD 74.5 million in 2025. The strong demand in the United States is supported by the high occurrence of digestive system disorders that require specialized diagnostic and therapeutic procedures. Healthcare providers in the country are increasingly adopting advanced endoscopic technologies to improve diagnostic accuracy and treatment outcomes. Continuous innovation in imaging technologies and the integration of advanced visualization capabilities are further supporting the demand for modern duodenoscope systems across hospitals and specialized medical centers.

Key companies operating in the Global Duodenoscopes Market include Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, PENTAX MEDICAL, Ambu, Ottomed Endoscopy, SonoScape, and STORZ. Companies in the Global Duodenoscopes Market are implementing several strategic initiatives to strengthen their competitive position and expand market reach. Leading manufacturers are investing significantly in research and development to introduce advanced endoscopic technologies that improve imaging quality, safety features, and overall device performance. Many organizations are focusing on developing innovative designs that enhance infection control and simplify device reprocessing. Strategic partnerships with healthcare institutions and medical technology providers are also helping companies accelerate product adoption and expand clinical applications. In addition, manufacturers are increasing their global distribution networks and strengthening service support for healthcare facilities. Continuous product innovation, regulatory approvals in multiple regions, and the introduction of next-generation endoscopic imaging technologies are enabling companies to reinforce their presence in the duodenoscopes market.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key Market Trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Category trends
  • 2.2.4 Sales channel trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of gastrointestinal diseases
    • 3.2.1.2 Technological advancements in devices
    • 3.2.1.3 Rising awareness and diagnosis rates
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost and stringent regulatory requirements
  • 3.2.3 Market opportunities
    • 3.2.3.1 Surge in integrated AI and data analytics
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pipeline analysis
• 3.6 Pricing analysis, 2025 (Driven by primary research)
• 3.7 Reimbursement scenario
• 3.8 Consumer insights (Driven by primary research)
• 3.9 Technology landscape
  • 3.9.1 Current technologies
  • 3.9.2 Emerging technologies
• 3.10 Gap analysis
• 3.11 Impact of AI and generative AI on the market
• 3.12 Porter's analysis
• 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Reusable duodenoscopes
• 5.3 Single-use duodenoscopes

Chapter 6 Market Estimates and Forecast, By Category, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Video duodenoscopes
• 6.3 Fiber optic duodenoscopes

Chapter 7 Market Estimates and Forecast, By Sales Channel, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Direct sales
• 7.3 Distributors

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Ambu
• 10.2 Boston Scientific Corporation
• 10.3 Fujifilm Holdings Corporation
• 10.4 Olympus Corporation
• 10.5 Ottomed Endoscopy
• 10.6 PENTAX MEDICAL
• 10.7 SonoScape
• 10.8 STORZ